Table: Sawai Pharmaceutical -9-MTH group results

SAWAI group

10/02/2017 06:00

Feb 10 (Reuters)-  
             Sawai Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2016        Dec 31, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              101.38               92.38           134.50     
                   (+9.7 pct)          (+15.2 pct)      (+8.9 pct)   
  Operating           17.90               19.33            23.50     
                   (-7.4 pct)          (+11.1 pct)      (+1.4 pct)   
  Recurring           17.87               19.11            23.30     
                   (-6.5 pct)          (+10.1 pct)      (+1.2 pct)   
  Net                 13.69               14.01            17.50     
                   (-2.2 pct)          (+19.6 pct)      (+2.0 pct)   
  EPS              371.35 yen          380.14 yen       474.67 yen   
  EPS Diluted      371.13 yen          379.87 yen                    
  Ann Div                              120.00 yen       130.00 yen   
  -Q2 div           65.00 yen           55.00 yen                    
  -Q4 div                               65.00 yen        65.00 yen   
   
  NOTE - Sawai Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T 
  ((Tokyo Headline News Desk +813 6441 1812))